title: Experience in a short-term trial with 4-aminopyridine in cerebellar ataxia.
authors.forename: I
authors.initials: I
authors.lastname: Giordano
authors.forename: M
authors.initials: M
authors.lastname: Bogdanow
authors.forename: H
authors.initials: H
authors.lastname: Jacobi
authors.forename: K
authors.initials: K
authors.lastname: Jahn
authors.forename: M
authors.initials: M
authors.lastname: Minnerop
authors.forename: L
authors.initials: L
authors.lastname: Schoels
authors.forename: M
authors.initials: M
authors.lastname: Synofzik
authors.forename: J
authors.initials: J
authors.lastname: Teufel
authors.forename: T
authors.initials: T
authors.lastname: Klockgether
mesh_terms: D015761:4-Aminopyridine / Q000009:adverse effects / Q000627:therapeutic use*; D002524:Cerebellar Ataxia / Q000188:drug therapy* / Q000235:genetics; D002908:Chronic Disease; D004185:Disability Evaluation; D006801:Humans; D026902:Potassium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D026902:Potassium Channel Blockers; D015761:4-Aminopyridine